RCMI Coordinating Center (RCMI CC) Header Logo

Connection

James Chambers to Neoplasms, Experimental

This is a "connection" page, showing publications James Chambers has written about Neoplasms, Experimental.
Connection Strength

0.502
  1. Desamero MJ, Kakuta S, Tang Y, Chambers JK, Uchida K, Estacio MA, Cervancia C, Kominami Y, Ushio H, Nakayama J, Nakayama H, Kyuwa S. Tumor-suppressing potential of stingless bee propolis in in vitro and in vivo models of differentiated-type gastric adenocarcinoma. Sci Rep. 2019 12 23; 9(1):19635.
    View in: PubMed
    Score: 0.178
  2. Son NV, Uchida K, Thongtharb A, Chambers JK, Kishimoto TE, Tomiyasu H, Ohmi A, Tsujimoto H, Nakayama H. Establishment of cell line and in vivo mouse model of canine Langerhans cell histiocytosis. Vet Comp Oncol. 2019 Sep; 17(3):345-353.
    View in: PubMed
    Score: 0.170
  3. Ushigusa T, Koyama Y, Ito T, Watanabe K, Chambers JK, Hasegawa A, Uchida K, Kanegi R, Hatoya S, Inaba T, Sugiura K. Innate immunity mediated by dendritic cells/macrophages plays a central role in the early period in tumor treatment using gene of Mycobacterium tuberculosis antigen. J Vet Med Sci. 2018 Feb 09; 80(2):190-196.
    View in: PubMed
    Score: 0.155
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support